- Powerhouse combination of tomosynthesis and automated breast ultrasound highlight leadership in breast health care
- Boca Raton Regional Hospital, an early adopter of interconnected comprehensive solution
CHICAGO - December 1, 2014 – Effectively combatting a leading form of cancer in women today requires empowered patients, enabled clinicians, pioneering technology – and a personalized care plan to bring them all together. For the first time at the Radiological Society of North America (#RSNA14) annual meeting, GE Healthcare (NYSE: GE) is not just envisioning, but bringing to life an interconnected, adaptable future of breast screening and diagnosis designed to help meet the needs of each unique woman.
Putting advanced medical insights into the hands of clinicians and patients, GE‘s breast care solution helps clinicians provide individualized screening and diagnostic options in a comprehensive environment: 3D breast tomosynthesis, automated breast ultrasound (ABUS), contrast-enhanced spectral mammography (CESM), molecular breast imaging (MBI), breast magnetic resonance imaging (MRI), and healthcare IT workflows connecting them together. A customized combination of any or all of these offerings can help enable confident and rapid diagnoses for women, and their unique breast health needs.
Boca Raton Regional Hospital in Boca Raton, Florida, is the first institution in the United States to implement GE Healthcare’s comprehensive portfolio of breast health solutions.
“Our philosophy is to have women come in for screening, receive the right supplemental screening based on her individual needs, and walk out with confidence in her results or a clear diagnosis that same day,” said Dr. Kathy Schilling, medical director of Christine E. Lynn Women’s and Wellness Institute of Boca Raton Regional Hospital. “Based on individualized needs, our patients now have access to GE Healthcare’s 3D tomosynthesis, advanced mammography, SensorySuite, CESM, ABUS, breast MRI, and MBI – all tied together by GE’s Centricity* Solutions for Enterprise Imaging software. By offering one comprehensive solution in one place, we want to provide one day diagnoses for more patient-centered care.”
At the core of GE Healthcare’s breast care continuum are two exceptional technologies unveiled earlier this year: SenoClaire* and Invenia ABUS. SenoClaire, a leading 3D breast tomosynthesis solution, helps clinicians find cancers in women with all types of breast tissue. With no increase in radiation dose compared to a standard 2D mammogram, SenoClaire uses a “step-and-shoot” method that reduces blur and increases image sharpness. Invenia ABUS is the only technology approved by the FDA for screening the 40 percent of American women who have dense breast tissue. A first-of-its-kind study published recently in “Radiology” concluded that screening with ABUS in women with dense breasts improves breast cancer detection by an average of 27 percent over mammography alone1.
GE Healthcare’s solution is the only to offer 3D imaging and ABUS, which provides clinicians with innovative tools to meet the unique needs of women with all tissue types and nearly half the female population with dense breasts.
“As a woman and a radiologist, I can tell you that every woman’s breast health needs are as unique as she is,” said Jessie Jacob, MD, MMM, chief medical officer of Breast Health at GE Healthcare. “It is time we break down barriers by handing clinicians one interconnected solution that cuts across breast care products: a comprehensive portfolio that adapts quickly to meet the needs of each unique woman. This future starts today.”
*Trademark of the General Electric Company
¹Assessing Improvement in Detection of Breast Cancer with Three-dimensional Automated Breast US in Women with Dense Breast Tissue: The SomoInsight Study. Rachel F. Brem, MD, László Tabár, MD, Stephen W. Duffy, MSc, Marc F. Inciardi, MD, Jessica A. Guingrich, MD, Beverly E. Hashimoto, MD, Marla R. Lander, MD, Robert L. Lapidus, MD, Mary Kay Peterson, MD, Jocelyn A. Rapelyea, MD, Susan Roux, MD, Kathy J. Schilling, MD, Biren A. Shah, MD, Jessica Torrente, MD, Ralph T. Wynn, MD, Dave P. Miller, MS
GE Healthcare at #RSNA14
Each year in Chicago, the conference of the Radiological Society of North America (RSNA) provides a forum for showcasing the latest innovations in medical imaging. If you are attending the conference, please visit GE Healthcare at booth number 4039 in McCormick Place south hall. Throughout the week of the event, GE Healthcare will distribute news and information using these digital platforms:
- Digital Press Kit: http://invent.ge/RSNA14
- Facebook: https://www.facebook.com/GEHealthcare
- Flickr: https://www.flickr.com/photos/gehealthcare
- Instagram: http://instagram.com/gehealthcare
- LinkedIn: http://www.linkedin.com/company/gehealthcare
- Tumblr: http://gehealthcare.tumblr.com/
- Twitter: http://twitter.com/gehealthcare
- YouTube: http://www.youtube.com/user/gehealthcare
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter - great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients. For more information about GE Healthcare, visit our website at www.gehealthcare.com.